Hjem › Major depresjon › Arkansas › Little Rock
Kliniske studier for Major depresjon i Little Rock, AR
14 studier for Major depresjon søker deltakere på steder i og rundt Little Rock (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
RekruttererFase 3
- Preferred Research Partners, Inc., Little Rock
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
RekruttererFase 3
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · 15 mi unna
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
RekruttererFase 3
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · 15 mi unna
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
RekruttererFase 3
- Vanda Investigational Site, Little Rock
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RekruttererFase 4
- Neurocrine Clinical Site, Bryant · 15 mi unna
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
RekruttererFase 3
- SanRo Clinical Research Group, Bryant · 15 mi unna
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
RekruttererFase 2
- Draig Clinical Site, Little Rock
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
RekruttererFase 2
- Draig Clinical Site, Little Rock
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RekruttererFase 3
- Neurocrine Clinical Site, Bryant · 15 mi unna
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
RekruttererFase 3
- Woodland International Research Group, Little Rock
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RekruttererFase 3
- Neurocrine Clinical Site, Little Rock
- Neurocrine Clinical Site, Bryant · 15 mi unna
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
RekruttererFase 2
- Preferred Research Partners /ID# 279206, Little Rock
- Woodland International Research Group /ID# 277605, Little Rock
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
RekruttererFase 2
- Pillar Clinical Research, LLC, Little Rock
- Preferred Research Partners, Inc., Little Rock
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RekruttererFase 3
- Neurocrine Clinical Site, Little Rock
Major depresjon-studier i andre byer
- New York City, NY36 studier
- Boston, MA31 studier
- Atlanta, GA25 studier
- Philadelphia, PA23 studier
- Orlando, FL19 studier
- Miami, FL18 studier
- Chicago, IL17 studier
- Tampa, FL17 studier
- San Diego, CA16 studier
- Houston, TX16 studier
- Austin, TX13 studier
- Las Vegas, NV13 studier
Andre studier i Little Rock
- Schizofreni19 studier
- Kreft (alle typer)14 studier
- Akut myelogen leukemi13 studier
- Ikke-småcellet lungekreft13 studier
- Fedme11 studier
- Endometriekreft10 studier
- Depresjon10 studier
- Type 2-diabetes10 studier
- Lungekreft9 studier
- Kardiovaskulær sykdom9 studier
- Blærekreft9 studier
- Hjertesvikt9 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.